Panion & BF Biotech Inc (1760) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Panion & BF Biotech Inc (1760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$73.31 Million ≈ $2.31 Million USD) by net assets (NT$1.90 Billion ≈ $59.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 1760 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Panion & BF Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Panion & BF Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Panion & BF Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Panion & BF Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AMA Group Ltd AU:AMA	0.125x
ECB Bancorp Inc. NASDAQ:ECBK	0.016x
Superior Uniform Group Inc NASDAQ:SGC	-0.009x
Aroa Biosurgery Ltd AU:ARX	0.045x
Companhia Brasileira de Distribuição SA:PCAR3	0.455x
FutureFuel Corp NYSE:FF	-0.007x
Min Aik Technology Co Ltd TW:3060	-0.038x
Bioversys AG SW:BIOV	N/A

Annual Cash Flow Conversion Efficiency for Panion & BF Biotech Inc (2009–2024)

The table below shows the annual cash flow conversion efficiency of Panion & BF Biotech Inc from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Panion & BF Biotech Inc (1760) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$1.92 Billion ≈ $60.56 Million	NT$351.19 Million ≈ $11.06 Million	0.183x	+96.80%
2023-12-31	NT$1.91 Billion ≈ $60.21 Million	NT$177.42 Million ≈ $5.59 Million	0.093x	-61.96%
2022-12-31	NT$2.01 Billion ≈ $63.24 Million	NT$489.87 Million ≈ $15.43 Million	0.244x	+17.59%
2021-12-31	NT$1.93 Billion ≈ $60.90 Million	NT$401.23 Million ≈ $12.64 Million	0.208x	+1868.28%
2020-12-31	NT$1.24 Billion ≈ $39.07 Million	NT$-14.55 Million ≈ $-458.56K	-0.012x	-117.54%
2019-12-31	NT$1.36 Billion ≈ $42.83 Million	NT$90.98 Million ≈ $2.87 Million	0.067x	+15.01%
2018-12-31	NT$1.35 Billion ≈ $42.55 Million	NT$78.58 Million ≈ $2.48 Million	0.058x	-57.36%
2017-12-31	NT$835.25 Million ≈ $26.31 Million	NT$113.97 Million ≈ $3.59 Million	0.136x	-37.91%
2016-12-31	NT$806.41 Million ≈ $25.41 Million	NT$177.22 Million ≈ $5.58 Million	0.220x	+192.12%
2015-12-31	NT$775.03 Million ≈ $24.42 Million	NT$58.30 Million ≈ $1.84 Million	0.075x	-29.74%
2014-12-31	NT$710.84 Million ≈ $22.40 Million	NT$76.11 Million ≈ $2.40 Million	0.107x	-18.47%
2013-12-31	NT$656.55 Million ≈ $20.68 Million	NT$86.22 Million ≈ $2.72 Million	0.131x	+825.27%
2012-12-31	NT$278.86 Million ≈ $8.79 Million	NT$3.96 Million ≈ $124.70K	0.014x	+111.67%
2011-12-31	NT$296.98 Million ≈ $9.36 Million	NT$-36.12 Million ≈ $-1.14 Million	-0.122x	-164.01%
2010-12-31	NT$301.62 Million ≈ $9.50 Million	NT$-13.89 Million ≈ $-437.77K	-0.046x	-119.43%
2009-12-31	NT$324.61 Million ≈ $10.23 Million	NT$76.98 Million ≈ $2.43 Million	0.237x	--

About Panion & BF Biotech Inc

TW:1760 Taiwan Biotechnology

Market Cap

$161.80 Million

NT$5.14 Billion TWD

Market Cap Rank

#17462 Global

#902 in Taiwan

Share Price

NT$59.90

Change (1 day)

+0.50%

52-Week Range

NT$58.80 - NT$73.40

All Time High

NT$228.22